Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Canna Care Docs

SEPTEMBER 26, 2019

Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. Job Responsibilities: The Medical Practitioner, Medical Doctor (MD), ARPN or Doctor of Osteopathy (DO), will be responsible for: · Perform non-invasive exams and obtain health histories. About Canna Care Docs…. Why Work for CannaCareDocs?

History 40

History DEA Therapy Patients 40

SpeedWeed

MAY 15, 2021

The subjects had been experiencing PTSD symptoms for an average of 14 years, and 84 percent had a history of developmental trauma. Doblin and his fellow researchers initially began exploring the therapeutic potential of MDMA back in the early 1980s, but these studies ground to a halt when the DEA banned ecstasy in 1985.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

SMPL

AUGUST 14, 2019

That includes a lack of access to financial services that lead such companies to operate on a largely cash basis, making them targets for crime. A report attached to the measure provides context on state-level legalization efforts, the history of federal prohibition and the “resulting regulatory quagmire.”.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

JUNE 15, 2021

Reinvests funds to support programs that work on expanding access to substance use treatment, support harm reduction services, and reduce the criminalization of individuals who use drugs by supporting the development or expansion of pre-arrest diversion programs. Ensures individuals with drug convictions can gain access to drivers’ licenses.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Cannabis Law Report

JULY 9, 2021

Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval. Drug Enforcement Agency (“DEA”). Briefing is still under way, with the DEA’s responsive brief submitted on June 25, 2021, and the petitioners’ reply due July 16, 2021. AIMS Institute, PLLC.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

FEBRUARY 28, 2022

Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Because they were criminalized for decades, the U.S.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine.

Therapy 53

Therapy DEA Patients Clinical Trials 53

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development 117

Research and Development Education Agriculture Patients 117

SpeedWeed

MARCH 18, 2021

They also wrote: The study sample included participants with a history of cannabis use. Wasn’t the DEA going to let others grow research-grade cannabis? Veterans groups advocating for more access to cannabis, meanwhile, are applauding the newly-published study. It tested at only 9% THC. PTSD widespread in veteran communities.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Canna Law Blog

OCTOBER 29, 2019

Plans must also ensure that samples are representative of an entire hemp lot and the state or tribal agency charged with testing must have unrestricted access to all land, building, and structures used for the cultivation, handling, and storage of hemp. Applicants must submit their contact information and a criminal history report.

Hemp 66

Hemp THC Compliance Compliance 66

Cannabis Law Report

APRIL 14, 2022

pursuant to Drug Enforcement Agency (DEA) or state-level programs). Before legalization, illicit grow sites did not have access to water utilities and were typically grown in arid/remote areas, often depleting local surface water and shallow aquifers not suited to intensive use.

Environment 52

Environment Agriculture Compliance Compliance 52

Veriheal

DECEMBER 21, 2022

This makes history by enacting the first piece of standalone federal cannabis reform legislation in U.S. The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. The law gives the U.S. The law gives the U.S. Descheduling Cannabis.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Cannabis Law Report

OCTOBER 20, 2021

Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. So, given the history and credibility of the Institute, why did BoA terminate the 10-year banking relationship with SRI? The Hemp Gazette reports.

Banking 52

Banking Clinical Trials DEA History 52

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. We will also translate existing clinical research, making it more accessible to courts, lawmakers, federal agencies, and the public. Chloe Reichel: Can you describe the primary goals of POPLAR?

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

MAY 24, 2022

Facts and Procedural History: The Controlled Substances Act was passed in 1970 and created a single legal framework for regulating substances that are thought to have a high risk of abuse and addiction. To consider the full impact of this Supreme Court decision it is necessary to delve into the history of the Controlled Substance Act.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

NOVEMBER 2, 2021

The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. The second argument is based on a DEA interim final rule on the topic of synthetic THC.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

SEPTEMBER 23, 2019

Cannabis use, both medically and recreationally, is prevalent throughout history. Surveying marijuana use is essential to gauge public health implications of increased access to marijuana, cannabinoid, and cannabis products. Background. Extensive evidence. 1 In the U.S. and 2.3%, respectively. 48 Incarceration impacts health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JUNE 9, 2021

You might just get a slap on the wrist from state officers depending on the quantity, your criminal history, and the reason behind the stop. You could still find yourself dealing with Big Daddy DEA, even with a medical marijuana card at the ready, and even if you’re still within the state that issued it. The takeaways.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

APRIL 8, 2022

To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

JUNE 1, 2021

A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. The Company will host a conference call and audio webcast with David Klein , CEO and Mike Lee , CFO at 10:00 AM Eastern Time on June 1, 2021. Webcast Information.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 24, 2019

The second path would be the administrative action by the Drug Enforcement Agency [“DEA”] and its Diversion Control Division. Will the mandate for the DEA be changed to oversee another special agricultural legal crop or a medicine ? You can access the whitepapers to view here. Inbound Investment Structuring.

Legalization 58

Legalization Collective DEA Banking 58

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

Cannabis Law Report

AUGUST 6, 2021

A replay will be accessible by webcast until 11:59 PM ET on November 4, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. The Company will host a conference call and audio webcast with David Klein , CEO and Mike Lee , CFO at 10:00 AM Eastern Time on August 6, 2021. Webcast Information. Replay Information.

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

DECEMBER 28, 2018

On October 17, Canada made history by becoming the second nation (after Uruguay) to federally legalize adult-use cannabis. Bummer: Patients Are Still Struggling for Cannabis Access. There’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

SEPTEMBER 19, 2019

Back on June 4, 2018 , in honor of Hemp History Week , Jessica Walters at CannaMD explored the background of “ marijuana’s controversial cannabis brother, hemp – a non-psychoactive variety of the cannabis plant, cannabis sativa. However, this is not a new debate. of the state’s total population. ” In October 2018, the U.S.

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

JULY 30, 2019

Like others, Dr. Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S.

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 14, 2021

“Closing the door on broadly supported incremental reforms like the SAFE Banking Act while the Senate seeks compromise on farther-reaching bills hurts the possibilities for consensus and ignores the very real needs of small business operators who have repeatedly said that access to banking services and traditional lending is an existential issue.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

SEPTEMBER 29, 2021

Many producers expressed concerns that the DEA’s interim final rule would criminalize the processing of hemp extracts. The bill would also get rid of the USDA’s requirement that only DEA laboratories can test hemp products. There are currently zero DEA registered labs in my home state and [only] one in New England,” Pingree said.

Hemp 52

Hemp Banking Legislation Policy 52